You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
步長製藥(603858.SH)及子公司擬合計投資2080萬元設立一家全資子公司及兩家控股子公司
格隆匯 03-21 15:37

格隆匯3月21日丨步長製藥(603858.SH)公佈,為完善公司戰略發展佈局,在細分管理的基礎上獲取市場競爭優勢,實現“中國的強生,世界的步長”的規劃,促進業務發展,公司擬對外投資設立一家全資子公司及兩家控股子公司。

公司擬出資1000萬元,設立全資子公司“北京步長大廈物業運營有限公司”(暫定名,以工商局核准為準);

公司控股子公司湖南眾測擬出資1000萬元,設立湖南眾測的全資子公司“長沙眾測生物科技有限公司”(暫定名,以工商局核准為準);

公司擬出資80萬元,與他方共同設立控股子公司“步長健康產業(西安)有限責任公司”(暫定名,以工商局核准為準)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account